- Home
- EBF vs DCTH Comparison
EBF vs DCTH Comparison
Compare EBF & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBF
- DCTH
- Stock Information
- Founded
- EBF 1909
- DCTH 1988
- Country
- EBF United States
- DCTH United States
- Employees
- EBF N/A
- DCTH N/A
- Industry
- EBF Office Equipment/Supplies/Services
- DCTH Medical/Dental Instruments
- Sector
- EBF Consumer Discretionary
- DCTH Health Care
- Exchange
- EBF Nasdaq
- DCTH Nasdaq
- Market Cap
- EBF 488.0M
- DCTH 426.3M
- IPO Year
- EBF N/A
- DCTH N/A
- Fundamental
- Price
- EBF $17.76
- DCTH $11.41
- Analyst Decision
- EBF
- DCTH Strong Buy
- Analyst Count
- EBF 0
- DCTH 4
- Target Price
- EBF N/A
- DCTH $24.00
- AVG Volume (30 Days)
- EBF 167.2K
- DCTH 960.5K
- Earning Date
- EBF 06-23-2025
- DCTH 08-04-2025
- Dividend Yield
- EBF 5.64%
- DCTH N/A
- EPS Growth
- EBF N/A
- DCTH N/A
- EPS
- EBF 1.51
- DCTH N/A
- Revenue
- EBF $388,707,000.00
- DCTH $53,850,000.00
- Revenue This Year
- EBF $0.48
- DCTH $162.10
- Revenue Next Year
- EBF N/A
- DCTH $32.97
- P/E Ratio
- EBF $11.80
- DCTH N/A
- Revenue Growth
- EBF N/A
- DCTH 1068.87
- 52 Week Low
- EBF $17.15
- DCTH $7.17
- 52 Week High
- EBF $25.75
- DCTH $18.23
- Technical
- Relative Strength Index (RSI)
- EBF 39.96
- DCTH 36.92
- Support Level
- EBF $17.53
- DCTH $10.95
- Resistance Level
- EBF $18.45
- DCTH $11.74
- Average True Range (ATR)
- EBF 0.34
- DCTH 0.61
- MACD
- EBF -0.07
- DCTH -0.08
- Stochastic Oscillator
- EBF 20.44
- DCTH 24.33
About EBF Ennis Inc.
Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialities, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360º Custom LabelsSM, ColorWorx, Enfusion, among others.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.